Files in This Item:


Title: Measuring transparency to improve good governance in the public pharmaceutical sector: Pakistan
Authors: World Health Organization, Regional Office for the Eastern Mediterranean
Issue Date: 2017
Publisher: World Health Organization. Regional Office for the Eastern Mediterranean
Place of publication: Cairo
Language: English
Abstract: This report presents the results of an assessment to measure transparency in the pharmaceutical sector in Pakistan. National transparency assessment is the beginning of a process aimed at bringing about desirable and sustainable changes in the governance of the sector. It provides a comprehensive picture of the level of transparency and the potential vulnerability to corruption of the eight essential functions of the pharmaceutical sector, namely: Registration of Medicines, Licensing of Pharmaceutical Establishments, Inspection and Market Control of Medicines, Medicines Promotion Control, Control of Clinical Trials, Selection of Medicines, Procurement of Medicines and Distribution of Medicines. The results of this assessment will inform the development and implementation of a national good governance for medicines programme in Pakistan
Description: 119 p.
Keywords: Health Systems
Subject: Pharmacology
Pharmaceutical Services
Public Sector
Drug Approval
Drug Evaluation
Context: organization and administration
ISBN: 978-92-9022-204-0
Other Identifiers: 978-92-9022-205-7 [Online]
License: CC BY-NC-SA 3.0 IGO
License URL:
Appears in Collections:EMRO Publications

Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.